Solid Tumors That Overexpress HER2 (HER2 Positive)
1 clinical trials · Condition
◉ Watch Solid Tumors That Overexpress HER2 (HER2 Positive)
| Record | Firm | Date |
|---|---|---|
| Phase 1, Multiple Ascending Dose Study of Anti-HER2 FCAB FS102 in HER2 Positive Solid Tumors (Anti HER2 Fcab) (NCT02286219) | Bristol-Myers Squibb | 2014-11-04 |
Track Solid Tumors That Overexpress HER2 (HER2 Positive) automatically
Every clearance here is in the API, with alerts when new ones post.